Gerresheimer (OTCMKTS:GRRMF) Stock Price Up 16.7% – Here’s What Happened

Gerresheimer AG (OTCMKTS:GRRMF – Get Free Report)’s share price traded up 16.7% during trading on Friday. The stock traded as high as $33.90 and last traded at $33.90. 2,000 shares traded hands during trading, an increase of 541% from the average daily volume of 312 shares. The stock had previously closed at $29.05.

Analyst Ratings Changes

A number of research analysts recently issued reports on GRRMF shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Gerresheimer in a report on Tuesday, August 4th. UBS Group raised Gerresheimer from a “sell” rating to a “neutral” rating in a research report on Tuesday, August 4th. Finally, Sanford C. Bernstein raised shares of Gerresheimer from an “underperform” rating to a “market perform” rating in a research report on Wednesday, July 1st. Four research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce”.

Get Our Latest Stock Report on Gerresheimer

Gerresheimer Trading Up 16.7%

The business has a fifty day moving average price of $30.79 and a 200 day moving average price of $29.48.

Gerresheimer Company Profile

(Get Free Report)

Gerresheimer AG is a Germany-based manufacturer of packaging and drug-delivery systems for the pharmaceutical, biotechnology and cosmetics industries. The company develops and produces glass and plastic packaging, including vials, ampoules, syringes, cartridges, bottles and other containers used to store and administer medicines and other sensitive products.

Its portfolio also includes medical devices and drug-delivery solutions such as prefillable syringes, inhalers, pens and other injection-related systems.

Recommended Stories

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.